Page 1 of Clinical Trials for Drug SCH 58235, 205 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)
Last Updated: April 4, 2008
Condition(s): Hypercholesterolemia
2
Completed
A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)(COMPLETED)
Last Updated: April 15, 2010
Condition(s): Hypercholesterolemia; Familial Hypercholesterolemia; Homozygous Sitosterolemia
3
Completed
A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)(COMPLETED)
Last Updated: April 15, 2010
Condition(s): Hypercholesterolemia; Familial Hypercholesterolemia; Homozygous Sitosterolemia
4
Completed
Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects
Last Updated: February 12, 2008
Condition(s): Pharmacokinetics; Drug Interactions; Hypercholesterolemia; Immunosuppression
5
Completed
Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects
Last Updated: February 12, 2008
Condition(s): Pharmacokinetics; Drug Interactions; Hypercholesterolemia; Immunosuppression
6
Active, not recruiting
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
Last Updated: June 23, 2010
Condition(s): Peripheral Arterial Disease
7
Completed
Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)(COMPLETED)
Last Updated: March 31, 2008
Condition(s): Hypercholesterolemia; Atherosclerosis
8
Active, not recruiting
Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels
Last Updated: March 15, 2011
Condition(s): Hypercholesterolemia; Hyperlipidemia
9
Completed
Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2
Last Updated: September 23, 2010
Condition(s): Pharmacokinetics; Drug Interactions; Pharmacodynamics; Intestinal Transporter Expression
10
Completed
Effect of Simvastatin and Ezetimibe on Lipid and Inflammation
Last Updated: April 14, 2010
Condition(s): Prediabetes; Hypercholesterolemia; Inflammation; Cardiovascular Risk
11
Completed
Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both
Last Updated: April 17, 2007
Condition(s): Cholesterol, LDL
12
Completed
SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia
Last Updated: March 3, 2008
Condition(s): Lipoidosis
13
Recruiting
Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.
Last Updated: June 30, 2011
Condition(s): ST-Segment Elevation Myocardial Infarction
14
Completed
Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.
Last Updated: May 17, 2012
Condition(s): Hypercholesterolaemia
15
Completed
A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)
Last Updated: September 23, 2010
Condition(s): Hypercholesterolemia
16
Completed
Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults
Last Updated: March 1, 2011
Condition(s): HIV Infections
17
Completed
EZETROL® Re-examination Study (MK0653-175)(COMPLETED)
Last Updated: September 26, 2011
Condition(s): Hypercholesterolemia
18
Completed
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
Last Updated: April 1, 2008
Condition(s): Hypercholesterolemia; Atherosclerosis; Coronary Artery Disease
19
Terminated
Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)
Last Updated: February 21, 2012
Condition(s): Hypercholesterolemia, Familial; Lipid Metabolism, Inborn Errors
20
Not yet recruiting
Physiological Study of Human Cholesterol Metabolism and Excretion
Last Updated: May 21, 2012
Condition(s): Coronary Heart Disease; Cardiovascular Disease; Dyslipidemia; Disorder of Cholesterol Metabolism

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+SCH+58235

Page 1 of Clinical Trials for Drug SCH 58235, 205 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About